• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ImmunoPrecise Antibodies Ltd. - Common Stock (NQ:IPA)

1.734 +0.004 (+0.20%)
Streaming Delayed Price Updated: 9:43 AM EDT, Jul 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 99,728
Open 1.720
Bid (Size) 1.740 (2)
Ask (Size) 1.750 (27)
Prev. Close 1.730
Today's Range 1.720 - 1.800
52wk Range 0.2700 - 2.410
Shares Outstanding 19,169,216
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ImmunoPrecise Antibodies (IPA) Reports Full Fiscal Year 2025 Results, Record Fourth Quarter Revenue, and Record Fourth Quarter Adjusted EBITDA
July 29, 2025
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
Earnings Scheduled For July 29, 2025
July 29, 2025
 
Via Benzinga

Performance

YTD
+285.2%
+285.2%
1 Month
+63.5%
+63.5%
3 Month
+291.8%
+291.8%
6 Month
+232.7%
+232.7%
1 Year
+108.9%
+108.9%

More News

Read More
ImmunoPrecise Releases New Findings Showing LENSai™ Quickly Flags Anti-Drug-Antibody Risk—Long Before the Clinic
July 24, 2025
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
ImmunoPrecise Appoints Healthcare Data Visionary Jeff Fried to Advisory Board
July 21, 2025
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2025 on July 29, 2025
July 16, 2025
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
Tech Momentum Surges as IPA, HIT, SNYR, PNPN.V, KAPA and Others Drive Investor Awareness – More Stocks Inside
July 15, 2025
Via AB Newswire
Topics Artificial Intelligence Earnings
These stocks are moving in today's session
July 14, 2025
Via Chartmill
ImmunoPrecise Regains Compliance with Nasdaq Minimum Bid Price Requirement
July 14, 2025
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
Let's uncover which stocks are experiencing notable gaps during today's session.
July 07, 2025
Via Chartmill
ImmunoPrecise Antibodies Appoints Industry Veteran Jon Lieber to Board of Directors
July 07, 2025
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
ImmunoPrecise Validates LENSai Epitope Mapping Platform Across Broad Range of Unseen Therapeutic Targets Beyond Training Data
July 03, 2025
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
ImmunoPrecise Advances Universal Dengue Vaccine, Confirming Safety, Immune Activation, and Structural Stability Using its LENSai™ Platform Powered by Patented HYFT® Technology
June 24, 2025
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
On Friday, there are stocks with unusual volume. Let's take a look.
June 13, 2025
Via Chartmill
AI & Tech Breakout: PRSO, IPA, NEHC, SOAR Lead Today’s Innovation Surge – More Movers Inside
June 12, 2025
Via AB Newswire
Topics Artificial Intelligence
Let's take a look at the stocks that are in motion in today's session.
June 12, 2025
Via Chartmill
There are notable gap-ups and gap-downs in today's session.
June 12, 2025
Via Chartmill
AI-Designed GLP-1 Peptides from ImmunoPrecise Antibodies Surpass Semaglutide in Receptor Activation Studies
June 12, 2025
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
ImmunoPrecise Announces AI-Driven Breakthrough in Universal Dengue Vaccine Discovery
June 05, 2025
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
ImmunoPrecise Antibodies Engages CORE IR to Enhance Investor Engagement Efforts
May 21, 2025
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
ImmunoPrecise Antibodies (IPA) to Present at Maxim Group’s 2025 Virtual Tech Conference
May 20, 2025
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
IPA’s LENSai™ Platform Delivers X-Ray–Level Epitope Mapping Insights in Hours, Matching Gold-Standard Methods with Greater Speed
May 12, 2025
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA's Shift to Non-Animal Testing Methods
April 11, 2025
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
Wondering what's happening in today's after-hours session?
April 10, 2025
Via Chartmill
ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025
March 28, 2025
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
Earnings Scheduled For March 28, 2025
March 28, 2025
Via Benzinga

Frequently Asked Questions

Is ImmunoPrecise Antibodies Ltd. - Common Stock publicly traded?
Yes, ImmunoPrecise Antibodies Ltd. - Common Stock is publicly traded.
What exchange does ImmunoPrecise Antibodies Ltd. - Common Stock trade on?
ImmunoPrecise Antibodies Ltd. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ImmunoPrecise Antibodies Ltd. - Common Stock?
The ticker symbol for ImmunoPrecise Antibodies Ltd. - Common Stock is IPA on the Nasdaq Stock Market
What is the current price of ImmunoPrecise Antibodies Ltd. - Common Stock?
The current price of ImmunoPrecise Antibodies Ltd. - Common Stock is 1.734
When was ImmunoPrecise Antibodies Ltd. - Common Stock last traded?
The last trade of ImmunoPrecise Antibodies Ltd. - Common Stock was at 07/30/25 09:43 AM ET
What is the market capitalization of ImmunoPrecise Antibodies Ltd. - Common Stock?
The market capitalization of ImmunoPrecise Antibodies Ltd. - Common Stock is 33.23M
How many shares of ImmunoPrecise Antibodies Ltd. - Common Stock are outstanding?
ImmunoPrecise Antibodies Ltd. - Common Stock has 33M shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap